Skip to main content

Chemistry

 C. Corre
Dr Christophe Corre
Bacterial signalling: new chemical keys to unlock the production of novel microbial antibiotics.
 deeth.jpg
Professor Rob Deeth
Inorganic computational chemistry
 fox.jpg
Dr David Fox
Synthetic methodology including asymmetric and catalytic reactions, kinetics and DFT modelling
 marsh.jpg
Dr Andrew Marsh
Combining organic chemistry and molecular design in the synthesis of functional molecules
 shipman.jpg
Professor Mike Shipman

 

Chemical synthesis of functional organic molecules

 tosin.jpg
Dr Manuela Tosin
Chemical probes/tools aiming at (i) uncovering the details of complex mechanisms involved in natural product biosynthesis; (ii) generating novel natural products of improved pharmacological activity; (iii) exploring new sources of natural products
 wills.jpg
Professor Martin Wills
Synthetic chemistry and asymmetric catalysis
 scott.jpg
Professor Peter Scott
Metallo-organic chemistry, particularly the design of self-assembling chiral systems; their applications as medicines for challenging diseases
 sadler.jpg
Professor Peter Sadler
Chemistry of metals in medicine (bioinorganic chemistry, inorganic chemical biology and medicine)
 gibson.jpg
Professor Matthew Gibson
Organic, polymer and carbohydrate chemistry to address global healthcare issues
 rodger.jpg
Professor Alison Rodger
Biomacromolecule structure and function including DNA, membrane proteins and fibrous proteins including application to bacterial cell division
 challis.jpg
Professor Greg Challis
Natural products chemistry and biology
 lewandowski.jpg
Jozef Lewandowski
Developing and applications of NMR (primarily but not exclusively solid state) methodology for studying structure and dynamics of proteins and nucleic acids
 bugg.jpg
Professor Tim Bugg
Enzymes involved in bacterial cell wall peptidoglycan biosynthesis, as targets for the development of novel antibacterial agents
 haddleton.jpg
Professor David M. Haddleton
New antimicrobial therapies based on lipopeptides and polymeric materials such as hydrogels, nanogels and polymeric prodrugs (for systemic delivery) for the treatment of the Gram negative and Gram positive infections.